Ginkgo Bioworks Holdings (DNA) Revenue (QoQ) (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) Revenue (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.69% |
| Dec 31, 2025 | -14.01% |
| Sep 30, 2025 | -21.71% |
| Jun 30, 2025 | 29.75% |
| Mar 31, 2025 | -12.81% |
| Dec 31, 2024 | -50.76% |
| Sep 30, 2024 | 58.43% |
| Jun 30, 2024 | 48.13% |
| Mar 31, 2024 | -84.39% |
| Dec 31, 2023 | 338.54% |
| Sep 30, 2023 | -31.20% |
| Jun 30, 2023 | -0.17% |
| Mar 31, 2023 | -17.89% |
| Dec 31, 2022 | 48.02% |
| Sep 30, 2022 | -54.09% |
| Jun 30, 2022 | -14.12% |
| Mar 31, 2022 | 13.41% |
| Dec 31, 2021 | 91.33% |
| Sep 30, 2021 | 77.86% |
| Jun 30, 2021 | -1.05% |